Evidence map›Paper›PMID 41071100›Full record

ArticleAntimicrobial agents and chemotherapy2025

Olorofim activity against multidrug-resistant

Ruoning Xue, Shenghan Gao, Sybren de Hoog, Anne van Diepeningen, Shaoqin Zhou, Tianyi Xu, Like Fokkens, Ruoyu Li, Lin Bai, Zhe Wan and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. New Perspectives on Antimicrobial Agents: Fosmanogepix.Antimicrobial agents and chemotherapy · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ruoning XueDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.ORCID 0000-0002-4218-5387
Shenghan GaoInstitute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Sybren de HoogResearch Center for Medical Mycology, Peking University, Beijing, China.ORCID 0000-0002-5344-257X
Anne van DiepeningenBU Biointeractions and Plant Health, Wageningen Plant Research, Wageningen University and Research, Wageningen, the Netherlands.
Shaoqin ZhouDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
Tianyi XuDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Like FokkensLaboratory of Phytopathology, Plant Sciences Group, Wageningen University and Research, Wageningen, the Netherlands.
Ruoyu LiDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Lin BaiDepartment of Biophysics, School of Basic Medical Sciences, Peking University, Beijing, China.
Zhe WanDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Paul E VerweijDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0002-8600-9860
Yinggai SongDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.ORCID 0000-0002-1644-6942

Funding

National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital) 2024IR31
6 · The paper itself

Abstract

Fungi in the genus

Indexed as

Antifungal AgentsDrug Resistance, Multiple, FungalFusariumPyrimidinesAcetamidesHumansMicrobial Sensitivity TestsMorpholinesMultilocus Sequence TypingPiperazinesPyrrolesAcetamidesAntifungal AgentsMorpholinesolorofimPiperazinesPyrimidinesPyrrolesFusariumolorofimsusceptibility

Identifiers

PMID41071100
PMCPMC12587566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.